Vinod K. Bansal, MD

Speaks

Languages

Hindi

About

Academic Title

Professor

Leadership Title

Medical Director, Chronic Dialysis

Additional Resources

Education & Certifications

Education

Education:
Jawaharlal Nehru Medical College, University of Rajasthan (1964)

Fellowship:
University of Colorado College of Medicine (1967)

Fellowship:
Cedars-Sinai Medical Center (1968)

Fellowship:
New York University Medical Center (1969)

Residency:
University of Illinois Medical Center (1973)

Board Certifications

Nephrology, Nephrology, American Board of Internal Medicine Subspecialty (1976)

Publications

  • Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure. Robbin, V.; Bansal, V.; Siddiqui, F.; Allen, M.; Hoppensteadt-Moorman, D.; Kantarcioglu, B.; Abulencia, E.; Magpoc, E.; Fareed, J.; Syed, M.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients With End-Stage Renal Disease. Karumanchi, P.; Sridharan, D.; Hoppensteadt, D.; Siddiqui, F.; Fareed, J.; Bansal, V.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients. Allen, M.; Bansal, V.; Siddiqui, F.; Hoppensteadt, D.; Krupa, E.; Fareed, J.; Kantarcioglu, B.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Arterial-renal Syndrome in Patients with ESRD, a New Disease Paradigm. Goldstein, J.; Dieter, R. S.; Bansal, V.; Wieschhaus, K.; Dieter, R. S.; Bontekoe, E.; Hoppensteadt, D.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Procalcitonin as a Marker of Comorbid Atrial Fibrillation in Chronic Kidney Disease and History of Sepsis. Bontekoe, J.; Bansal, V.; Lee, J.; Syed, M.; Hoppensteadt, D.; Maia, P.; Walborn, A.; Liles, J.; Vasaiwala, S.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Relationship Between 25-Hydroxyvitamin D, Renin, and Collagen Remodeling Biomarkers in Atrial Fibrillation. Patel, D.; Druck, A.; Hoppensteadt, D.; Bansal, V.; Brailovsky, Y.; Syed, M.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Osteopontin Levels in Patients With Chronic Kidney Disease Stage 5 on Hemodialysis Directly Correlate With Intact Parathyroid Hormone and Alkaline Phosphatase. Druck, A.; Patel, D.; Bansal, V.; Hoppensteadt, D.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Circulating Biomarker Levels in Patients With Stage 5 Chronic Kidney Disease With Respect to Neurovascular Diseases. Lee, J.; McMillan, R.; Skiadopoulos, L.; Bansal, V.; Biller, J.; Hoppensteadt, D.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial Fibrillation. Bontekoe, J.; Lee, J.; Bansal, V.; Syed, M.; Hoppensteadt, D.; Maia, P.; Walborn, A.; Liles, J.; Brailovsky, E.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney Disease. Lee, J.; Bontekoe, J.; Trac, B.; Bansal, V.; Biller, J.; Hoppensteadt, D.; Maia, P.; Walborn, A.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Diversity of the midstream urine microbiome in adults with chronic kidney disease. Kramer, H.; Kuffel, G.; Thomas-White, K.; Wolfe, A. J.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Brubaker, L.; Flanigan, R.; Koval, J.; Wadhwa, A.; Zilliox, M. J.; International urology and nephrology
  • Elevated extracellular nucleosomes and their relevance to inflammation in stage 5 chronic kidney disease. Phan, T.; Mcmillan, R.; Skiadopoulos, L.; Walborn, A.; Hoppensteadt, D.; Fareed, J.; Bansal, V.; International angiology : a journal of the International Union of Angiology
  • Biomarkers of Endothelial, Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure. McMillan, R.; Skiadopoulos, L.; Hoppensteadt, D.; Guler, N.; Bansal, V.; Parasuraman, R.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Isakova, T.; Nickolas, T. L.; Denburg, M.; Yarlagadda, S.; Weiner, D. E.; Gutiérrez, O. M.; Bansal, V.; Rosas, S. E.; Nigwekar, S.; Yee, J.; Kramer, H.; American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report. Bansal, V. K.; Herzog, C. A.; Sarnak, M. J.; Choi, M. J.; Mehta, R.; Jaar, B. G.; Rocco, M. V.; Kramer, H.; American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Biomarker profiling of plasma samples utilizing RANDOX biochip array technology. Saluk, J.; Hoppensteadt, D.; Syed, D.; Liles, J.; Abro, S.; Walborn, A.; Bansal, V.; Fareed, J.; International angiology : a journal of the International Union of Angiology
  • Inflammatory and Metabolic Syndrome Biomarker Analysis of Vascular Outcomes in End-stage Renal Disease. Sweigert, P. J.; Bansal, V. K.; Hoppensteadt, D. A.; Saluk, J. L.; Syed, D. A.; Fareed, J.; The International journal of angiology : official publication of the International College of Angiology, Inc
  • Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey). Bress, A. P.; Kramer, H.; Khatib, R.; Beddhu, S.; Cheung, A. K.; Hess, R.; Bansal, V. K.; Cao, G.; Yee, J.; Moran, A. E.; Durazo-Arvizu, R.; Muntner, P.; Cooper, R. S.; Circulation
  • Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures. Small, C.; Kramer, H. J.; Griffin, K. A.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Markossian, T. W.; BMC nephrology
  • Ultrafiltration Rate Thresholds in Maintenance Hemodialysis: An NKF-KDOQI Controversies Report. Kramer, H.; Yee, J.; Weiner, D. E.; Bansal, V.; Choi, M. J.; Brereton, L.; Berns, J. S.; Samaniego-Picota, M.; Scheel, P.; Rocco, M.; American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Urinary incontinence and diuretic avoidance among adults with chronic kidney disease. Patel, M.; Vellanki, K.; Leehey, D. J.; Bansal, V. K.; Brubaker, L.; Flanigan, R.; Koval, J.; Wadhwa, A.; Balasubramanian, N.; Sandhu, J.; Kramer, H.; International urology and nephrology
  • Effect of erythropoietin stimulating agents on vascular endothelial growth factor levels in patients with end stage renal disease. Saluk, J. L.; Bansal, V. K.; Hoppensteadt, D. A.; Syed, D. A.; Abro, S.; Fareed, J.; International angiology : a journal of the International Union of Angiology
  • Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD. Markossian, T.; Burge, N.; Ling, B.; Schneider, J.; Pacold, I.; Bansal, V.; Leehey, D.; Stroupe, K.; Chang, A.; Kramer, H.; American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Strategies to promote adherence to nutritional advice in patients with chronic kidney disease: a narrative review and commentary. Beto, J. A.; Schury, K. A.; Bansal, V. K.; International journal of nephrology and renovascular disease
  • Neurologic Complications of Chronic Kidney Disease. Vellanki, K.; Bansal, V. K.; Current neurology and neuroscience reports
  • Immunoenzymatic and biochip array profiling of the biomarkers of inflammation and hemostatic activation processes in ESRD. Richards, J.; Bansal, V.; Iqbal, O.; Hoppensteadt, D.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Prevalence of metabolic syndrome in patients with end stage renal disease and relevance of biomarkers. Saluk, J.; Bansal, V.; Hoppensteadt, D.; Syed, D.; Abro, S.; Fareed, J.; International angiology : a journal of the International Union of Angiology
  • Nervous system disorders in dialysis patients. Bansal, V. K.; Bansal, S.; Handbook of clinical neurology
  • Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease. Kaneva, K.; Bansal, V.; Hoppensteadt, D.; Cunanan, J.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal disease. Sharain, K.; Hoppensteadt, D.; Bansal, V.; Singh, A.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Upregulation of inflammatory mediators in end-stage renal disease as measured using biochip array technology. Davis, R.; Bansal, V.; Litinas, E.; Hoppensteadt, D.; Thethi, I.; Nelson, K.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Upregulation of surrogate markers of inflammation and thrombogenesis in patients with ESRD: pathophysiologic and therapeutic implications. Nelson, K.; Thethi, I.; Cunanan, J.; Hoppensteadt, D.; Bajwa, R.; Fareed, J.; Bansal, V.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin. Adiguzel, C.; Bansal, V.; Litinas, E.; Cunanan, J.; Iqbal, O.; Nelson, K.; Kannan, M.; Hoppensteadt, D.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic products. Adiguzel, C.; Jeske, W. P.; Hoppensteadt, D.; Walenga, J. M.; Bansal, V.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Nutrition interventions to address cardiovascular outcomes in chronic kidney disease. Beto, J. A.; Bansal, V. K.; Advances in chronic kidney disease
  • Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor. Tobu, M.; Iqbal, O.; Fareed, D.; Chatha, M.; Hoppensteadt, D.; Bansal, V.; Fareed, J.; Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. Beto, J. A.; Bansal, V. K.; Journal of the American Dietetic Association
  • The effect of blood draw methodology on selected nutritional parameters in chronic renal failure. Beto, J. A.; Bansal, V. K.; Kahn, S.; Advances in renal replacement therapy
  • Hemodialysis prognostic nutrition index as a predictor for morbidity and mortality in hemodialysis patients and its correlation to adequacy of dialysis. Council on Renal Nutrition National Research Question Collaborative Study Group. Beto, J. A.; Bansal, V. K.; Hart, J.; McCarthy, M.; Roberts, D.; Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
  • Interventions for other risk factors: tobacco use, physical inactivity, menopause, and homocysteine. Beto, J. A.; Bansal, V. K.; American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Using the hemodialysis prognostic nutrition index and urea reduction ratio to predict morbidity and mortality: a pilot study of the 1995 council on renal nutrition national research question. Beto, J. A.; Bansal, V. K.; Gohlke, N. P.; Hano, J. E.; Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
  • Variation in blood sample collection for determination of hemodialysis adequacy. Council on Renal Nutrition National Research Question Collaborative Study Group. Beto, J. A.; Bansal, V. K.; Ing, T. S.; Daugirdas, J. T.; American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Treatment of lupus nephritis: a meta-analysis of clinical trials. Bansal, V. K.; Beto, J. A.; American journal of kidney diseases : the official journal of the National Kidney Foundation
  • Use of pharmacy computer prescription database to access hypertensive patients for mailed survey research. Beto, J. A.; Listecki, R. E.; Meyer, D. A.; Budhy, R. J.; Bansal, V. K.; The Annals of pharmacotherapy
  • Correlations of Na+-Li+ exchange activity with Na+ and Li+ binding and phospholipid composition in erythrocyte membranes of white hypertensive and normotensive individuals: a nuclear magnetic resonance investigation. Chi, Y.; Mota de Freitas, D.; Sikora, M.; Bansal, V. K.; Hypertension (Dallas, Tex. : 1979)
  • Longitudinal effects of cyclosporine administration at 0 to 60 months after heart transplantation. Costanzo, M. R.; Beto, J. A.; Potempa, L. D.; Bansal, V. K.; Heroux, A. L.; Kao, W. G.; Pifarre, R.; Johnson, M. R.; Transplantation proceedings
  • Quality of life in treatment of hypertension. A metaanalysis of clinical trials. Beto, J. A.; Bansal, V. K.; American journal of hypertension
  • A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study. Stiff, P. J.; McKenzie, R. S.; Potempa, L. D.; Albain, K.; Koch, D.; Braud, E.; Bansal, V. K.; Weidner, M. K.; Lanzotti, V. J.; Chun, H. G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Nuclear magnetic resonance studies of lithium transport in erythrocyte suspensions of hypertensives. Ramasamy, R.; Mota de Freitas, D.; Bansal, V. K.; Dorus, E.; Labotka, R. J.; Clinica chimica acta; international journal of clinical chemistry
  • Pneumocystis carinii pneumonia: a lethal complication of "pulse" methylprednisolone therapy. Kozeny, G. A.; Quinn, J. P.; Bansal, V. K.; Vertuno, L. L.; Hano, E.; The International journal of artificial organs